Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-30

FDA Approved: BALSALAZIDE DISODIUM — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for balsalazide disodium from Apotex Corp., enabling the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colazal (balsalazide disodium) (balsalazide disodium)

Snippet

SUPPL AP for BALSALAZIDE DISODIUM (BALSALAZIDE DISODIUM)